Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Toyama Chemical: Geninax Lifts Sales 61.7%
June 2, 2008
- OPINION／Leaders Are Readers
June 2, 2008
- Agreement Rate of Over 70% by End of Sept. Acceptable?
June 2, 2008
- GENERICS NEWS IN BRIEF
May 26, 2008
- Daiichi Sankyo: Sales Down 5.3% due to One-time Effects of Merger
May 26, 2008
- I'rom to Market Ranbaxy's Generic Amlodipine
May 26, 2008
- Astellas: Tough Year Expected in FY2008 due to Prograf Patent Expiration
May 26, 2008
- Will Generics Take Off? (4)
May 26, 2008
- Takeda's R&D Spending to Hit Record High of \485 Bil. in FY2008
May 26, 2008
- BUSINESS NEWS IN BRIEF
May 26, 2008
- Takeda Completes Acquisition of Millennium
May 26, 2008
- Toho Pharm.: Record-High Sales and Profits
May 26, 2008
- Kyowa Hakko Kirin Aims at Becoming Global Specialty Pharma Leveraging Biotechnology
May 26, 2008
- Suzuken: Sales Up 8.7% for Wholesale Business
May 26, 2008
- All-Patient Survey Confirms Enbrel's Safety, Efficacy
May 26, 2008
- Alfresa: Sales Up 11.3% to \1,769 Bil.
May 26, 2008
- Mediceo Paltac: Sales Up 4.1% to \2,255 Bil.
May 26, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 26, 2008
- All Univ. Hospitals Have Adopted Preminent: Banyu
May 26, 2008
- MEDICAL DEVICE NEWS IN BRIEF
May 26, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…